Erste Asset Management Gmb H Agios Pharmaceuticals, Inc. Transaction History
Erste Asset Management Gmb H
- $11.9 Trillion
- Q2 2025
A detailed history of Erste Asset Management Gmb H transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Erste Asset Management Gmb H holds 2,326,489 shares of AGIO stock, worth $82.3 Million. This represents 0.65% of its overall portfolio holdings.
Number of Shares
2,326,489
Previous 2,229,900
4.33%
Holding current value
$82.3 Million
Previous $65.4 Billion
18.28%
% of portfolio
0.65%
Previous 0.84%
Shares
23 transactions
Others Institutions Holding AGIO
# of Institutions
234Shares Held
61.8MCall Options Held
288KPut Options Held
235K-
Farallon Capital Management LLC San Francisco, CA5.77MShares$204 Million0.86% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.68MShares$201 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$172 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.59MShares$127 Million2.72% of portfolio
-
Commodore Capital LP New York, NY2.33MShares$82.3 Million7.21% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $1.94B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...